Risk of Parkinson's disease after tamoxifen treatment

BACKGROUND: Women have a reduced risk of developing Parkinson's disease (PD) compared with age-matched men. Neuro-protective effects of estrogen potentially explain this difference. Tamoxifen, commonly used in breast cancer treatment, may interfere with the protective effects of estrogen and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Latourelle, Jeanne C, Dybdahl, Merete, Destefano, Anita L, Myers, Richard H, Lash, Timothy L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862029/
https://www.ncbi.nlm.nih.gov/pubmed/20385012
http://dx.doi.org/10.1186/1471-2377-10-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862029/
https://www.ncbi.nlm.nih.gov/pubmed/20385012
http://dx.doi.org/10.1186/1471-2377-10-23

Ejemplares similares